Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

could cause or contribute to such differences include risks relating to: Teva`s ability to successfully develop and commercialize additional pharmaceutical products, the introduction of competing generic equivalents, the extent to which Teva may obtain U.S. market exclusivity for certain of its new generic products and regulatory changes that may prevent Teva from utilizing exclusivity periods, competition from brand-name companies that are under increased pressure to counter generic products, or competitors that seek to delay the introduction of generic products, the impact of consolidation of our distributors and customers, potential liability for sales of generic products prior to a final resolution of outstanding patent litigation, including that relating to the generic versions of Allegra(R) and Neurontin(R), the effects of competition on our innovative products, especially Copaxone(R) sales, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry, the difficulty of predicting U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, the regulatory environment and changes in the health policies and structures of various countries, our ability to achieve expected results though our innovative R&D efforts, Teva's ability to successfully identify, consummate and integrate acquisitions, potential exposure to product liability claims to the extent not covered by insurance, dependence on the effectiveness of our patents and other protections for innovative products, significant operations worldwide that may be adversely affected by terrorism, political or economical instability or major hostilities, supply interruptions or delays that could result from the complex manufacturing of our products and our global supply chain, environmental risks, fluctuations in currency, exchange and interest rates, and other factors that are discussed in Teva's Annual Report
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:7/31/2015)... NEW YORK , July 31, 2015  Seeger Weiss ... Drug Administration (FDA) issued a warning letter to C.R. Bard, ... for not taking adequate strides to correct violations the agency ... aware of these violations after the FDA cited them during ... 05, 2015, in Bard,s Tempe, AZ , ...
(Date:7/31/2015)... July 31, 2015 The Physician-Patient Alliance ... on July 28, 2015, "Surviving Your Hospital Stay: ... for Patient Safety." A sentence was ... read: "PPAHS is a member of ... Opioids. For more information on the National Coalition to ...
(Date:7/31/2015)... , July 31, 2015 ... decades of experience, the domestic pharmaceutical industry is strong, ... manufacture products to high international standards. One ... known is in sub-Saharan Africa: Morocco has quietly become ... South Africa . Indeed, Moroccan pharma ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3
... (NASDAQ: STXS ) today reported financial results ... for the period was $11.6 million, and included a ... announced an operating plan designed to ensure successful commercialization ... plan includes a realignment and reduction of operating expenses ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... for the second quarter of 2011.  For the three months ... $7.6 million, or $0.16 per share, as compared to a ... the second quarter of 2010.  As of June 30, 2011, ...
Cached Medicine Technology:Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 2Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 3Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 4Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 5Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 6Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 7Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™ 8Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results 2Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results 3Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results 4Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results 5
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of ... unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what ... of both companies have agreed to join their missions of purpose together to change ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, ... who are thought to have been behind the attack on Anthem Inc. which resulted ... zero day exploits, watering hole attacks and spear phishing campaigns. , For ...
(Date:8/1/2015)... ... 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair Care, ... small business donation to kick off the campaign for healing and Well-Being. , BeverlyD ... a complete line of raw, organic hair care products, as well as her book, ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine ... mile trek of the Appalachian Trail by stepping off Springer Mountain and heading ... , On July 26th Phil reached Connecticut and was greeted by friends and family. ...
(Date:7/31/2015)... NV (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source ... at the MGM Grand Garden Arena. Fans of every genre of music will have ... September 18th, the first day of the festival, the following artists will perform: Sam ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3
... Green alternative to travel with Telepresence success recognizedCINCINNATI, April ... PG ) was announced as one of ... 2009 for its success in reducing travel through the ... using Cisco,s Telepresence technology. This honor is part of ...
... To Be Heard,SAN MATEO, Calif., April 24 Horn ... for Children with Autism," the first-ever internet telecast focused ... 24, Saturday, April 25 and Sunday, April 26 at ... of World Autism Awareness Month, and will be co-sponsored ...
... GUANGZHOU, China, April 24 /PRNewswire-Asia/ -- ... "China Medicine" or "the Company"), a ... over-the-counter pharmaceuticals,traditional Chinese medicines ("TCM"), nutritional ... in the People,s Republic of China,(PRC), ...
... - Proceeds Will Advance Key New Products Including Completing ... Stent for Refractory Angina -, TSX ... (TSXV: NVC) today announced that it has completed a ... units at the price of $0.21 per unit for ...
... Pharmatech Oncology, Inc., a Research Management Organization ... of their Data Management business unit to the ... Data Management business unit is branded as C(3)DM ... Management business unit maintains and processes data for ...
... 24 April: Radioembolisation with Yttrium-90 (Y-90) glass microspheres ... with advanced HCC portal vein thrombosis, according ... the Annual Meeting of the European Association for ... , According to the researchers, these findings create ...
Cached Medicine News:Health News:Procter & Gamble Named as One of InfoWorld's Green 15 2Health News:Procter & Gamble Named as One of InfoWorld's Green 15 3Health News:Procter & Gamble Named as One of InfoWorld's Green 15 4Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 3Health News:China Medicine Corporation Achieves Major Milestone for rADTZ 2Health News:China Medicine Corporation Achieves Major Milestone for rADTZ 3Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 2Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 3Health News:Pharmatech Oncology Launches New Data Management Business Unit 2Health News:Future for radioembolisation in patients with advanced hepatocellular carcinoma 2
For the quantitative determination of luteinizing hormone (LH) concentration in human serum....
... a glycoprotein secreted by the anterior pituitary ... the intact LH molecule is a noncovalently-linked ... all have homologous alpha-subunits, however each hormone ... FSH production and secretion are stimulated by ...
Microwell-EIA for the detection of GAD Autoantibody....
... StreamLAB combines consolidated analytical ... with pre- and post-analytical ... innovative laboratory automation solution ... of today's laboratories, as ...
Medicine Products: